Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank75
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
10.31%
↓ 39% vs avg
Percentile
P75
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
16.99%
Historical baseline
PeriodValue
Q4 202510.31%
Q3 202578.70%
Q2 2025-5.41%
Q1 202572.38%
Q4 2024-23.24%
Q3 2024-15.77%
Q2 2024-8.28%
Q1 202438.00%
Q4 2023-9.34%
Q3 2023-4.69%
Q2 2023-4.97%
Q1 2023167.76%
Q4 2022-6.54%
Q3 20220.00%
Q2 20220.00%
Q1 20220.00%
Q4 20210.00%